Background-Migraine is an independent risk factor for stroke. Mechanisms underlying this association are unclear.
M
igraine is the most common neurological condition affecting young to middle-age adults. Up to one third of migraineurs experience transient neurological symptoms called aura. Migraine, particularly with aura, is associated with increased stroke risk both during and between attacks, especially in women. [1] [2] [3] [4] The biological basis for this association is unknown. Stroke risk is also increased in familial hemiplegic migraine (FHM), a monogenic migraine subtype with hemiplegic auras in addition to the common aura forms. 5 FHM is a useful model for common migraine with aura because of shared clinical features and trigger factors, female preponderance, and because two thirds of FHM patients and their first-degree relatives also have attacks of common migraine with or without aura. 6, 7 Neuronal network hyperexcitability and enhanced glutamate release have been implicated in both FHM and common forms of migraine. 8 
Clinical Perspective on p 345
FHM type 1 (FHM1) is caused by mutations in the CACNA1A gene, which encodes the pore-forming ␣ 1A subunit of neuronal Ca V 2.1 voltage-gated Ca 2ϩ channels. 9 Presynaptic Ca V 2.1 channels are major regulators of excitatory neurotransmitter release.
FHM1 mutant channels open with smaller depolarizations and stay open longer, 10 which augments presynaptic Ca 2ϩ entry and glutamate release, thereby enhancing brain excitability. 11 Transgenic mice expressing the human R192Q or S218L FHM1 mutation show an increased susceptibility to spreading depression, the electrophysiological substrate for migraine, and display characteristic clinical features of FHM such as transient hemiplegia. [12] [13] [14] Glutamatergic mechanisms and hyperexcitability also have been implicated in the pathogenesis of common forms of migraine. 15, 16 Genetic support for this link was recently obtained in a genome-wide association study identifying the astrocyte elevated gene 1 (AEG1), encoding a regulator of glial glutamate transporter EAAT2, as the first migraine gene. 16 Glutamate excitotoxicity also plays a pivotal role in the pathogenesis of stroke. Therefore, we hypothesized that genetic mutations conferring cerebral hyperexcitability and migraine susceptibility increase the vulnerability to ischemic stroke, as 1 mechanism to explain the migraine-stroke association. We tested this hypothesis using Ca V 2.1 S218L and R192Q transgenic mouse models of FHM1. The results reveal electrophysiological and hemodynamic mechanisms that accelerate hyperacute stroke evolution and worsen ischemic outcome in FHM1 mutants and suggest a pivotal role for enhanced glutamatergic transmission in increasing the vulnerability to ischemic stroke in susceptible migraineurs.
Methods

Experimental Animals
Experimental procedures were approved by the institutional review boards. A total of 267 male and female mice were used. Transgenic knock-in Cacna1a migraine mouse models homozygous (HOM) or heterozygous (HET) for R192Q or S218L FHM1 mutations were generated by a gene targeting approach. 14 The R192Q mutant strain was compared with C57BL6/J, backcrossed for 10 generations. The S218L mutants were compared with their wild-type (WT) littermates. Because stroke risk is highest in young adult migraineurs, mice were studied between 2 and 6 months of age. All experiments were carried out by blinded investigators, and confirmatory genotyping was done.
Systemic Physiological Monitoring
Arterial pH, PO 2 , PCO 2 , and blood pressure were measured via a femoral artery catheter under isoflurane anesthesia (2.5% induction, 1.5% maintenance, in 70% N 2 O and 30% O 2 ; Table I in the online-only Data Supplement). Rectal temperature was controlled at 37°C during ischemia, and intermittent monitoring was continued for 6 hours in a subset of mice.
Transient Filament Occlusion of the Middle Cerebral Artery
A nylon monofilament was inserted into the internal carotid artery via the external carotid artery followed by reperfusion after 30 or 60 minutes under isoflurane anesthesia (2.5% induction, 1.5% maintenance, in 70% N 2 O and 30% O 2 ) and laser Doppler monitoring. Mice were placed in a temperature-controlled incubator with easy access to food and water. Neurological outcomes were scored 24 hours after reperfusion with a 5-point scale: 0, normal; 1, forepaw monoparesis; 2, circling to left; 3, falling to left; 4, no spontaneous walking and depressed consciousness; and 5, death. Infarct volume was calculated by integrating the infarct area in ten 1-mm-thick 2,3,5-triphenyltetrazolium chloride (TTC)-stained coronal sections. Infarct volumes were calculated by subtracting the volume of ipsilateral noninfarcted tissue from the contralateral hemisphere. Ischemic swelling volumes were calculated by subtracting the volume of contralateral hemisphere from the volume of ipsilateral hemisphere. Glutamatergic mechanisms were tested by administering MK-801 (1 mg/kg IP; Sigma, St Louis, MO) 15 minutes before filament occlusion of the middle cerebral artery (fMCAO).
Magnetic Resonance Imaging
Apparent diffusion coefficient maps were acquired under isoflurane anesthesia with a 9.4-T magnetic resonance imaging (MRI) scanner (Bruker Biospin, Inc, Billerica, MA) 30 and 60 minutes after fMCAO (repetition time/echo time, 3000/27 milliseconds; b, 154 and 1294 s/mm 2 ; in-plane resolution, 180 ⅐ 180 m 2 ; slice thickness, 1 mm; number of averaging, 8). Means and SDs of the apparent diffusion coefficient in the cortex, striatum, hippocampus, and thalamus were extracted from the normal hemisphere, and thresholds were defined as mean minus 2 SDs to calculate lesion volumes. Normal systemic physiological parameters were confirmed under simulated MRI conditions in a separate group of mice (not shown).
Electrophysiological Recordings
After fMCAO, isoflurane-anesthetized mice were intubated and ventilated, and the femoral artery was catheterized for blood pressure and blood gas monitoring. Two intracortical glass micropipettes were placed, and extracellular recordings (depth, 250 m) were started within 15 minutes after the onset of ischemia and continued for Ϸ2 hours.
Receptor Autoradiography
The density and distribution of glutamate and GABA A receptors and glutamate reuptake sites were assessed on 10-m frozen sections with tritium-sensitive storage phosphor screens (GE Healthcare) as described. 17 
Laser Speckle Flowmetry
Spontaneously breathing mice (S218L HOM) were anesthetized with isoflurane as above, and the femoral artery was catheterized for blood pressure and gas measurements. Mice were placed in a stereotaxic frame; a temporal burr hole (2-mm diameter) was drilled above the zygomatic arch; and the distal middle cerebral artery was occluded with a microvascular clip for 60 minutes. Cortical perfusion was imaged during distal middle cerebral artery occlusion with laser speckle flowmetry through intact skull. 18 Cerebral blood flow (CBF) changes were calculated for each pixel relative to the preischemic baseline, and the area of cortex with residual CBF Յ30% was determined by thresholding. Neurological outcomes and infarcts were assessed 48 hours later as described above. In addition, the CBF threshold for tissue viability was estimated by superimposing the images of CBF and infarct. In the R192Q HOM strain, mice were intubated and ventilated to ensure normal arterial blood gas values, precluding survival for neurological and infarct assessment in this strain.
Anatomic Analysis of the Circle of Willis and Pial Collaterals
Mice were transcardially perfused with carbon black. The diameter of cerebral arteries, patency of the posterior communicating artery, and number of pial arterial anastomoses between the anterior, posterior, and middle cerebral arteries and their distance from midline were determined.
Absolute Resting CBF
Mice were anesthetized with ␣-chloralose (50 mg/kg) and ventilated. The femoral artery and external jugular vein were cannulated. Arterial blood was withdrawn continuously (0.3 mL/min).
N-isopropyl-[methyl-1,3-
14 C]-p-iodoamphetamine (1 Ci) was injected in 0.1 mL saline over 10 seconds. Twenty seconds after injection, the animal was decapitated, and the blood withdrawal was terminated simultaneously. The brain was removed, frozen, and dissected. CBF was calculated from the radioactivity in tissue and blood measured by liquid scintillation spectrometry. 
Statistical Analysis
Results
Enhanced Susceptibility to Anoxic and Peri-Infarct Depolarizations
Anoxic depolarization is characterized by a sudden loss of membrane ionic gradients, uncontrolled glutamate release, and cell swelling, triggered by the failure of Na ϩ /K ϩ ATPase under ischemic conditions. We found significantly earlier onset of anoxic depolarization in FHM1 mutants after fMCAO by monitoring its vasoconstrictive effect on cerebral vasculature as previously described ( Figure 1A and 1B). 18, 19 Importantly, the magnitude of CBF reduction in the ischemic core did not differ among groups in this fMCAO model, eliminating the possibility that faster anoxic depolarization rates were due to more severe ischemia (residual CBF, 10% to 17% of baseline in both S218L and R192Q; Pϭ0.634 and 0.599, respectively; data not shown).
PIDs are recurrent propagating depolarization waves akin to spreading depression that exacerbate the metabolic mismatch in penumbra and promote infarct growth during hyperacute stroke. 18 -21 We reasoned that FHM1 mutations that enhance spreading depression susceptibility 13 might also facilitate the occurrence of PIDs. Using intracortical microelectrode recordings during fMCAO, we indeed found a 2-fold increase in the frequency of PIDs in mutants over WT (5.3Ϯ1.3 versus 2.6Ϯ0.3 PIDs per hour; Pϭ0.028; Figure  1C -1F). In the mutants, PIDs sometimes occurred in clusters, possibly reflecting circling around the ischemic core (see below), 22 but otherwise did not differ from WT in terms of durations and amplitudes (not shown). Together, these data suggest that genetically enhanced susceptibility to spreading depression [11] [12] [13] [14] facilitates the occurrence of anoxic depolarization and PIDs during acute stroke as a novel mechanism to explain increased stroke vulnerability in migraineurs.
Rapid Growth of Hyperacute Ischemic Core on MRI
To assess whether enhanced susceptibility to anoxic depolarization and PIDs accelerates the hyperacute stroke evolution in FHM1 mutants, we performed serial diffusion-weighted MRI during fMCAO. Reduced apparent diffusion coefficient values on diffusion-weighted MRI reflect anoxic depolarization, loss of transmembrane ionic gradients, and cell swelling (ie, ischemic core). We found that the apparent diffusion coefficient lesion volumes expanded more rapidly in FHM1 mutant strains compared with WT controls (Figure 2 ). Al- . When the average PID frequency was calculated, these minor differences in recording duration were taken into account. E, Pooled cumulative PID numbers as a function of time after fMCAO was more than doubled in S218L HOM mice (*PϽ0.001; nϭ5 each). F, Experimental setup showing 2 intracortical glass micropipettes (E1, E2) placed outside the ischemic territory to detect PIDs after fMCAO. Shaded area indicates typical distribution of CBF deficit after fMCAO. HET indicates heterozygous.
though larger apparent diffusion coefficient lesion volumes were due primarily to more severe cortical involvement, the hyperacute lesion also encompassed the hippocampus and thalamus in S218L mutants.
Larger Perfusion Deficit During Hyperacute Stroke
Ischemic depolarizations compromise residual CBF within the territory supplied by the occluded artery via vasoconstrictive (ie, inverse) neurovascular coupling 18, 19 as a major determinant of outcome in cerebral ischemia. Using laser speckle flowmetry, we found larger cortical perfusion deficits after distal middle cerebral artery occlusion in FHM1 mutants (Figure 3A and 3B ; only S218L shown), associated with an increased frequency of PIDs (0.9Ϯ0.3 versus 4.6Ϯ1.2 PIDs per hour in WT and S218L HOM, respectively; Figure 3C ) that circled around the hypoperfused core in 38% of S218L mutants but not in the WT (movies I and II in the online-only Data Supplement). 22 In fact, higher PID frequencies were associated with larger cortical CBF deficits ( Figure 3D respectively; Pϭ0.019). These data suggest that ischemic depolarizations adversely influence the perfusion deficits and exacerbate the metabolic and O 2 supply-demand mismatch in FHM1 mutants, in part via vasoconstrictive (ie, inverse) neurovascular coupling as an additional hemodynamic mechanism for infarct growth. 18, 19, 23 Importantly, we found no difference in absolute resting CBF values between WT and R192Q HOM mice in the cortex, striatum, and cerebellum using the [ 14 C]iodoamphetamine method (Table II in the online-only Data Supplement), indicating that differences in preischemic resting CBF did not influence our measurements. We also confirmed this in WT and S218L HOM mice under isoflurane anesthesia using the correlation time values obtained by laser speckle imaging, which allow direct comparison of resting CBF among groups of mice (data not shown). 24, 25 Moreover, the incidence of incomplete circle of Willis, the diameter of its major branches, and the number and location of pial arterial anastomoses did not differ between WT and S218L HOM mice, suggesting that developmental differences in cerebrovascular anatomy did not contribute to worse perfusion deficits in the mutant mice ( Figure I and Table III in the online-only Data Supplement). 
scans, respectively. C, Thirty minutes after stroke onset, enlarged ADC lesion volumes in S218L HOM and R192Q HOM were due primarily to more severe cortical involvement (Pϭ0.015 and Pϭ0.023, respectively), although S218L HOM mutants also showed hyperacute ADC changes in the hippocampus and thalamus (Pϭ0.018 and Pϭ0.117, respectively). Of note, the average regional ADC values in the center of ischemic core did not significantly differ between FHM1 mutants and their WT controls, suggesting that cytotoxic cell swelling is complete in ischemic core in all groups (60Ϯ7% versus 56Ϯ6% in R192Q WT and HOM, and 57Ϯ5% versus 57Ϯ6% of contralateral hemisphere in S218L WT and HOM, respectively, 60 minutes after stroke onset). *PϽ0.05 vs WT. Ctx, cortex; Str, striatum; Thal, thalamus; Hipp, hippocampus.
Higher CBF Threshold for Tissue Survival
To determine the critical tissue perfusion level below which infarction ensued (ie, viability threshold), we calculated the regional CBF at the infarct margin by spatially coregistering the laser speckle perfusion map during distal middle cerebral artery occlusion with the infarct that developed 48 hours later (Figure 4) . We found that cortical tissue in S218L HOM mutants required a higher CBF level for survival compared with WT mice (42Ϯ3% versus 35Ϯ2% of baseline CBF, respectively; Pϭ0.048). These data underscore the importance of parenchymal mechanisms such as neuronal hyperexcitability and ischemic depolarizations as the main cause for increased vulnerability to ischemic stroke in FHM1 mutants independently of the severity of CBF deficit.
Worse Stroke Outcomes
Enhanced susceptibility to anoxic depolarization and PID and accelerated hyperacute infarct growth with more severe CBF deficits translated into worse stroke outcomes in FHM1 mutants. Transient fMCAO for 1 hour produced larger Figure 3 . FHM1 mutant mice develop larger areas of cerebral blood flow (CBF) deficit during distal middle cerebral artery occlusion (dMCAO) because of increased susceptibility to ischemic depolarizations. A, Representative laser speckle contrast images show the area of cortex with Յ30% residual CBF vs preischemic baseline (blue pixels) 60 minutes after dMCAO in wild-type (WT) and S218L homozygous (HOM) mice. Similar data were obtained with the R192Q strain (nϭ6 mutant and 6 WT; data not shown). Imaging was performed over the right hemisphere (light gray-shaded rectangle in the inset) through intact skull. Arrowheads indicate clip occlusion. B, The area of CBF deficit expanded rapidly in S218L HOM throughout the 60-minute dMCAO (*Pϭ0.004). C, Representative tracings show cortical blood flow reductions in penumbra (measured within the gray squares shown in A) after dMCAO. Anoxic depolarization triggers the first peri-infarct depolarization (PID; blue arrowheads), marking a second abrupt reduction in perfusion. Each subsequent PID (red arrowheads) causes a characteristic blood flow transient. D, The frequency of PIDs was higher in S218L HOM and correlated with the area of hypoperfused cortex 60 minutes after dMCAO (#PϽ0.001). Each symbol represents the PID frequency in individual mice. E, Representative 2,3,5-triphenyltetrazolium chloride-stained whole brains show enlarged infarcts in S218L HOM 48 hours after 60 minutes of dMCAO. F, The area of infarcts in 1-mm-thick coronal slices (0ϭanterior, 9ϭposterior) were larger in S218L HOM vs WT (*Pϭ0.016, S218L HOM vs WT for infarct areas). Integrated total infarct volumes were also larger in the mutants (19Ϯ3 versus 11Ϯ2 mm 3 , respectively; Pϭ0.008).
infarcts in both S218L and R192Q mutant mice compared with their WT controls ( Figure 5A ). Larger infarcts reflected predominantly more severe cortical involvement in both mutants (Ͼ70% of total infarct volume); however, the incidence of hippocampal or thalamic infarction also tended to be higher in the S218L mutant (present in 33% of S218L HET mice compared with 13% of WT; Pϭ0.1; data not shown), consistent with a higher incidence of subcortical infarction observed on MRI in this strain (see above). Functional outcomes, assessed with a combined death and neurological disability score as a clinically relevant end point, were worse in mutants compared with WT (the Table) . Indeed, the mortality rate was significantly higher in the S218L mutants, reaching 100% in the HOM within 24 hours after stroke onset ( Figure IIa in the online-only Data Supplement). The timing of death after stroke was variable (12Ϯ3 hours after stroke onset) and was not associated with overt seizure activity. Immediate postmortem examination revealed 2-fold larger infarcts in S218L HOM compared with WT mice euthanized at the same time point of death of each mutant after 60 minutes of fMCAO (95Ϯ15 versus 44Ϯ7 mm 3 , respectively; nϭ5 and 4; Pϭ0.031), suggesting that selection bias resulting Figure 3A . Images were spatially coregistered through the use of surface landmarks. Line profiles (blue and green oblique lines, labeled in mm) were drawn between lambda and the clip occluding the middle cerebral artery branch (yellow arrowheads). B, For each animal, cortical blood flow (CBF) was plotted along these line profiles as a function of distance from lambda using laser speckle images, and the blood flow level corresponding to the infarct edge was determined (red dotted lines). This value represented the CBF threshold for viability, below which the tissue infarcted in each mouse. C, The average viability threshold was significantly higher in S218L HOM mutants vs WT controls (Pϭ0.048), indicating that FHM1 mutant brains are more vulnerable to ischemia and require higher blood flow to survive. The numbers of mice are shown on each bar. *PϽ0.05 vs WT.
from high mortality in the mutants diminished the strain differences in outcome. These data were excluded from the overall comparisons among genotypes ( Figure 5 ) because of variable time of death. Ischemic brain swelling tended to be more severe in the mutants in proportion to the actual infarct volume and might have contributed to the high mortality in the S218L mutants.
To mimic transient ischemic attacks and to circumvent the high mortality rate in S218L HOM mice, we subjected this mutant strain to 30 minutes of fMCAO. With a shorter duration of ischemia, we did not detect overt infarcts in 27% of WT mice using TTC staining, whereas all S218L HET and HOM mutant mice developed conspicuous territorial infarcts (Pϭ0.077). Selective ischemic changes in scattered neurons were nevertheless present on histological examination of brains without an overt infarct (not shown). Infarct volumes were once again larger in the S218L mutants compared with WT mice (Figure 5B ). The volume of subcortical infarction, limited to the striatum in this shorter ischemia model, was also larger in the S218L HET compared with WT mice (17Ϯ4 and 5Ϯ1 mm 3 , respectively, in males, Pϭ0.002; 16Ϯ3 and 4Ϯ2 mm 3 , respectively, in females, Pϭ0.013). Despite the shorter ischemia duration, mortality was still high in the S218L HOM mutants (75%), but all HET mutants survived for at least 24 hours and showed a trend for worse functional outcome compared with WT (Pϭ0.086; the Table) .
Because classic migraine, sporadic migraine, and FHM are more prevalent in women of reproductive age 5,26 -29 and because susceptibility to spreading depression is higher in female FHM1 mutant mice compared with males, 13, 30 we also studied female mice and found an even more striking increase in infarct volumes in S218L HET compared with WT (Figure Table) and were excluded from infarct volume analysis. Because genetic backgrounds and infarct volumes differed significantly between WT controls of the 2 mutant strains, we did not directly compare S218L and R192Q mutants in this study. MK-801 (1 mg/kg IP 15 minutes before fMCAO) significantly reduced infarct volume in the S218L HET mutants (PϽ0.001 vs untreated S218L HET shown in A) but not in the WT (Pϭ0.061 vs untreated WT shown in A). Therefore, MK-801 was more efficacious in FHM1 mutants (Pϭ0.026 for infarct reduction by MK-801 between WT and FHM1 mutants). As a result, after MK-801, infarct and swelling volumes were comparable between WT and S218L HET mice (Pϭ0.367), as were neurological outcomes (the Table) . B, Thirty minutes of fMCAO also resulted in larger infarcts in male and female S218L mutants vs WT (Pϭ0.028). Despite shorter ischemia, 3 of 4 S218L HOM mutants died within 24 hours and were again excluded from infarct volume analysis; the data from the only surviving HOM mutant are shown. There was no mortality in the WT and HET groups after 30 minutes of fMCAO. The numbers of mice are shown on each bar. SE bars and P values refer to total volume (ie, infarct plus swelling). *PϽ0.05 vs WT, #PϽ0.05 vs untreated S218L HET after 60 minutes of fMCAO. 5B). To assess long-term tissue and neurological outcome (2 weeks) in FHM1 mutants, we subjected female S218L HET and WT mice to 30 minutes of fMCAO. However, we observed Ͼ60% mortality in the mutants predominantly between 24 and 96 hours, which precluded outcome comparisons between the mutant and WT strains at this late time point ( Figure IIb in the online-only Data Supplement). Together, these data indicate that mice expressing FHM1 mutations are particularly susceptible to infarction when challenged by cerebral arterial occlusion.
Enhanced Neuroprotective Efficacy of Glutamate Receptor Antagonist MK-801
FHM1 mutations enhance glutamate release, 11 and glutamate plays a pivotal role in spreading depression and ischemic depolarizations, as well as in excitotoxic cell death, mainly via the N-methyl-D-aspartate (NMDA) subtype of receptors. Therefore, we tested whether enhanced glutamatergic activity in FHM1 mutants is responsible for their vulnerability to infarction. Preischemic treatment with the NMDA receptor inhibitor MK-801 abolished the differences in stroke phenotype between genotypes. MK-801 reduced infarct volume by 45% in S218L HET compared with only 23% in WT ( Figure  5A ), and functional outcome was improved only in S218L mutants (the Table) .
As an important control, we also examined the density of glutamate and GABA A binding sites in the FHM1 mutant and WT mice using quantitative in vitro autoradiography and did not find overt differences (Figure III and Table IV in the online-only Data Supplement). These data are consistent with recent proteomics analysis of cortical synapses in this mutant 31 and suggest that enhanced susceptibility to ischemic depolarizations in FHM1 mutants is unlikely to reflect changes in neurotransmitter receptors and reuptake mechanisms.
Discussion
Our data provide a novel mechanism to explain the higher incidence of ischemic stroke in migraineurs. Two genetic mouse models expressing FHM1 mutations were at risk of developing large infarcts and worse neurological outcomes after transient focal cerebral ischemia. Consistent with the higher stroke risk in women compared with men with migraine with aura, we found more striking increases in infarct volume in female mutants compared with males. Faster anoxic depolarization rates, more frequent PIDs, and enhanced neuroprotective efficacy of the NMDA antagonist MK-801 in the mutants implicated glutamatergic neuronal hyperexcitability as 1 mechanism, and larger perfusion defects linked to ischemic depolarizations implicated vasoconstrictive neurovascular coupling as another. Therefore, neuronal and vascular mechanisms together render migraineurs more vulnerable to cerebral infarction on ischemia.
The data have clinical implications. In susceptible migraineurs, increased sensitivity to ischemia may predispose to strokes during mild ischemic events, which remain clinically silent or manifest only as transient ischemic attacks in nonmigraineurs. Moreover, elevated CBF threshold for viability, 32 a sign of increased vulnerability to ischemia, may promote rapid infarct expansion into tissue with milder perfusion deficits, diminish salvageable tissue at risk (ie, ischemic penumbra), and shorten the therapeutic window of acute stroke interventions in migraineurs. Lastly, higher mortality among the S218L mutants may have implications for malignant infarcts, large supratentorial strokes characterized by progressive loss of consciousness over 48 hours with up to 80% mortality if untreated. 33 To date, there has been no reliable predictor for malignant infarction, and history of migraine with aura (or its genetic determinants) may be 1 such marker increasing the risk of stroke progression and, in case of large territorial infarcts, the risk of death, as has recently been reported for hemorrhagic stroke in migraineurs. 34 
Mechanisms of Ischemic Vulnerability in FHM1 Mice
Biological mechanisms underlying the association between migraine and stroke are unknown, although in both diseases dynamic interactions among the constituents of the neurovascular unit are important to the pathophysiology. At the onset of cerebral ischemia, the gradual failure of Na ϩ /K ϩ -ATPase causes a slow rise in extracellular K ϩ and loss of neuronal membrane potential until a critical threshold for initiation of §PϽ0.001 and Pϭ0.086 for the effect of genotype on mortality and functional outcome score in males, respectively, and Pϭ0.02 for the effect of genotype on functional outcome score in females after 30 minutes of fMCAO. In the R192Q mutant strain, the mortality rate was 17%, 0%, and 14% in WT, HET, and HOM, respectively; neurological disability was not studied in this mutant strain.
anoxic depolarization is reached. 35, 36 FHM1 mutations shift the Ca V 2.1 channel opening voltage to more negative membrane potentials so that channels open with smaller depolarizations, triggering glutamate release, which can explain faster anoxic depolarization onset in the mutants. Glutamate is also critical for PIDs, which are spreading depolarization waves triggered in ischemic penumbra. Therefore, enhanced release in ischemic penumbra can also explain higher PID frequencies in FHM1 mutants. 11 Delayed Ca V 2.1 channel inactivation may exacerbate the excitotoxicity by prolonging the Ca 2ϩ influx and glutamate release during PIDs in penumbra. Moreover, PIDs exacerbate the metabolic mismatch in penumbra by stimulating O 2 and glucose consumption and by worsening tissue perfusion via vasoconstrictive (ie, inverse) neurovascular coupling, 18, 19, 23 particularly when they occur with high frequency and in clusters, as observed in FHM1 mutants. 19, [37] [38] [39] With each PID, more of the penumbra is incorporated into the core, accounting for concentric infarct growth over time. 22,40 -42 PIDs occur frequently in human brain after ischemic or hemorrhagic stroke and head trauma and appear to worsen patient outcomes, similar to experimental stroke. 38, [43] [44] [45] Hence, migraine with aura may be a risk factor for increased occurrence of PIDs and worse outcomes in human stroke, as recently suggested in subarachnoid hemorrhage. 46 
Association Between Migraine and Stroke
Our data in FHM1 mutant mice support shared genetic risk factors enhancing susceptibility to spreading depression as a mechanism to explain the migraine-stroke association. Shared genetic factors enhancing susceptibility to migraine and stroke such as NOTCH3 mutations in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy have been described. [47] [48] [49] [50] Indeed, NOTCH3 mutations, despite being exclusively expressed in vascular smooth muscle cells, augment susceptibility to spreading depression. 51 Mutations associated with FHM2 and FHM3 are also predicted to enhance neuronal excitability and spreading depression susceptibility possibly via glutamatergic mechanisms. 52 Glutamatergic mechanisms and hyperexcitability also are implicated in common forms of migraine by recent studies linking AEG1, encoding a regulator of glial glutamate transporter EAAT2, and KCNK18, encoding the TRESK potassium channel, to migraine. 15, 16 Vascular mechanisms (eg, endothelial dysfunction) have also been implicated in increasing stroke risk in migraineurs. 53, 54 Indeed, functional Ca v 2.1 channel expression has been reported in renovascular smooth muscle cells, 55, 56 but whether FHM1 mutations alter cerebrovascular physiology is not known. Together with parenchymal mechanisms that enhance vulnerability to perfusion deficits, vascular mechanisms might further augment stroke risk in migraineurs. For example, highly focal and mild ischemic vascular events such as microembolism 57 may trigger spreading depression more readily in migraineurs highly susceptible to ischemic depolarizations, providing a possible explanation for the origin of a subset of migraine auras.
Conclusions
A monogenic determinant of migraine with aura increases stroke vulnerability via glutamatergic mechanisms that enhance susceptibility to ischemic depolarizations akin to spreading depression and accelerate stroke evolution. Hence, our data put FHM1 mutations among the shared genetic determinants of migraine with aura and stroke. More work is needed to extrapolate these data to other monogenic syndromes and to the more common and genetically more complex forms of migraine with aura and to determine whether targeting hyperexcitability and spreading depression such as migraine prophylaxis 58 confers ischemic protection in susceptible mouse strains or in migraineurs. 
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